Home

Explore NIH Technologies

Explore work by over 1,500 NIH researchers   |   Available for Licensing & Collaboration

 
 
 
 
 
 
 
 
 
 
 
 
 

Explore Featured Research

Get updates on the latest and most exciting research coming out of NIH...

Read More >

Explore Featured Products

Novel and interesting products coming to market through NIH inventions and partnerships...

Read More >

Comirnaty®, colloquially known as the Pfizer vaccine, is a messenger RNA (mRNA) vaccine indicated for active immunization to prevent COVID-19 caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This vaccine by BioNTech/Pfizer received full FDA approval on August 23, 2021, after
Interested in partnering with or licensing from the NIH? The National Cancer Institute’s Michael Salgaller will be speaking at the Technology Transfer Society’s Technology Transfer and Innovation Forum Series. His presentation, titled Buying into the Buy Side: Technology Transfer Initiatives at the
Join NCI for a webinar discussing the opportunity to license or co-develop a potential therapeutic treatment for COVID-19. SARS-CoV-2 infects the host via its spike (S) protein, which contains a receptor binding domain (RBD) that binds to an angiotensin converting enzyme 2 (ACE2) receptor on human